EMEA-002012-PIP01-16-M03
Key facts
Invented name |
Namuscla
|
Active substance |
Mexiletine hydrochloride
|
Therapeutic area |
Other
|
Decision number |
P/0365/2021
|
PIP number |
EMEA-002012-PIP01-16-M03
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of myotonic disorders
|
Route(s) of administration |
|
Contact for public enquiries |
Lupin Europe GmbH
Tel. +41 526337025 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|